These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
512 related articles for article (PubMed ID: 27872075)
1. Pharmacokinetic-Pharmacodynamic Evaluation of Gepotidacin against Gram-Positive Organisms Using Data from Murine Infection Models. Bulik CC; Okusanya ÓO; Lakota EA; Forrest A; Bhavnani SM; Hoover JL; Andes DR; Ambrose PG Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872075 [TBL] [Abstract][Full Text] [Related]
2. In Vivo Pharmacodynamic Target Investigation of Two Bacterial Topoisomerase Inhibitors, ACT-387042 and ACT-292706, in the Neutropenic Murine Thigh Model against Streptococcus pneumoniae and Staphylococcus aureus. Lepak AJ; Seiler P; Surivet JP; Ritz D; Kohl C; Andes DR Antimicrob Agents Chemother; 2016 Jun; 60(6):3626-32. PubMed ID: 27044547 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic/Pharmacodynamic Evaluation of a Novel Aminomethylcycline Antibiotic, KBP-7072, in the Neutropenic Murine Pneumonia Model against Staphylococcus aureus and Streptococcus pneumoniae. Lepak AJ; Zhao M; Liu Q; Wang P; Wang Y; Bader JC; Ambrose PG; Andes DR Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30559140 [TBL] [Abstract][Full Text] [Related]
4. In Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection Model. Lepak AJ; Andes DR Antimicrob Agents Chemother; 2016 Aug; 60(8):4764-9. PubMed ID: 27216072 [TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target. Andes D; Craig WA Antimicrob Agents Chemother; 2006 Apr; 50(4):1376-83. PubMed ID: 16569855 [TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamics of the new des-f(6)-quinolone garenoxacin in a murine thigh infection model. Andes D; Craig WA Antimicrob Agents Chemother; 2003 Dec; 47(12):3935-41. PubMed ID: 14638504 [TBL] [Abstract][Full Text] [Related]
7. In vivo pharmacokinetics and pharmacodynamics of the lantibiotic NAI-107 in a neutropenic murine thigh infection model. Lepak AJ; Marchillo K; Craig WA; Andes DR Antimicrob Agents Chemother; 2015 Feb; 59(2):1258-64. PubMed ID: 25512404 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics/Pharmacodynamics of Peptide Deformylase Inhibitor GSK1322322 against Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus in Rodent Models of Infection. Hoover J; Lewandowski T; Straub RJ; Novick SJ; DeMarsh P; Aubart K; Rittenhouse S; Zalacain M Antimicrob Agents Chemother; 2016 Jan; 60(1):180-9. PubMed ID: 26482300 [TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamics of TD-1792, a novel glycopeptide-cephalosporin heterodimer antibiotic used against Gram-positive bacteria, in a neutropenic murine thigh model. Hegde SS; Okusanya OO; Skinner R; Shaw JP; Obedencio G; Ambrose PG; Blais J; Bhavnani SM Antimicrob Agents Chemother; 2012 Mar; 56(3):1578-83. PubMed ID: 22155835 [TBL] [Abstract][Full Text] [Related]
11. In vivo pharmacodynamic activity of the glycopeptide dalbavancin. Andes D; Craig WA Antimicrob Agents Chemother; 2007 May; 51(5):1633-42. PubMed ID: 17307987 [TBL] [Abstract][Full Text] [Related]
12. Comparative Pharmacodynamics of Telavancin and Vancomycin in the Neutropenic Murine Thigh and Lung Infection Models against Staphylococcus aureus. Lepak AJ; Zhao M; Andes DR Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28416551 [TBL] [Abstract][Full Text] [Related]
13. In vivo pharmacodynamics of lefamulin, the first systemic pleuromutilin for human use, in a neutropenic murine thigh infection model. Wicha WW; Craig WA; Andes D J Antimicrob Chemother; 2019 Apr; 74(Suppl 3):iii5-iii10. PubMed ID: 30949706 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic/Pharmacodynamic Evaluation of Solithromycin against Streptococcus pneumoniae Using Data from a Neutropenic Murine Lung Infection Model. Okusanya OO; Forrest A; Bhavnani SM; Fernandes P; Ambrose PG; Andes DR Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182534 [TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamics of the new fluoroquinolone gatifloxacin in murine thigh and lung infection models. Andes D; Craig WA Antimicrob Agents Chemother; 2002 Jun; 46(6):1665-70. PubMed ID: 12019073 [TBL] [Abstract][Full Text] [Related]
16. In vivo pharmacodynamic characterization of a novel plectasin antibiotic, NZ2114, in a murine infection model. Andes D; Craig W; Nielsen LA; Kristensen HH Antimicrob Agents Chemother; 2009 Jul; 53(7):3003-9. PubMed ID: 19414576 [TBL] [Abstract][Full Text] [Related]
17. In vivo pharmacodynamics of ceftobiprole against multiple bacterial pathogens in murine thigh and lung infection models. Craig WA; Andes DR Antimicrob Agents Chemother; 2008 Oct; 52(10):3492-6. PubMed ID: 18676887 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics/pharmacodynamics of lefamulin in a neutropenic murine pneumonia model with Staphylococcus aureus and Streptococcus pneumoniae. Wicha WW; Strickmann DB; Paukner S J Antimicrob Chemother; 2019 Apr; 74(Suppl 3):iii11-iii18. PubMed ID: 30949707 [TBL] [Abstract][Full Text] [Related]
19. In vivo pharmacodynamics of a new oxazolidinone (linezolid). Andes D; van Ogtrop ML; Peng J; Craig WA Antimicrob Agents Chemother; 2002 Nov; 46(11):3484-9. PubMed ID: 12384354 [TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics of a new streptogramin, XRP 2868, in murine thigh and lung infection models. Andes D; Craig WA Antimicrob Agents Chemother; 2006 Jan; 50(1):243-9. PubMed ID: 16377693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]